ÂÜÀòÂÒÂ×

David Morris serves as the Clinical Site Monitoring Manager and Senior Clinical Research Associate at Fractyl Health since January 2023, overseeing the Revita T2Di Pivotal Study focused on Type 2 Diabetes treatment. With extensive experience in clinical project management, David has held roles at various organizations, including Tigermed and inVentiv Health Clinical, where responsibilities encompassed site evaluations, monitoring visits, and compliance with regulatory standards. David's academic background includes a Master’s of Science in Pharmaceutical Systems Management and a Bachelor of Science in Industrial Engineering from the New Jersey Institute of Technology, supplemented by professional certification in Clinical Research Training from Rutgers. Additionally, David contributes as a consultant and adviser at the New Jersey Institute of Technology, assisting students in research methods and project management practices.